SciSparc Ltd. (NASDAQ:SPRC) Short Interest Up 1,435.0% in March

SciSparc Ltd. (NASDAQ:SPRC) was the recipient of a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 1,030,000 shares, an increase of 1,435.0% from the February 28th total of 67,100 shares. Based on an average daily trading volume, of 9,770,000 shares, the days-to-cover ratio is presently 0.1 days. Currently, 9.5% of the shares of the stock are short sold.

SciSparc Stock Performance

Shares of NASDAQ:SPRC opened at $0.31 on Friday. The firm has a 50 day moving average of $0.43 and a 200-day moving average of $0.35. SciSparc has a 12 month low of $0.20 and a 12 month high of $2.10.

SciSparc Company Profile

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution.